Work

Early preclinical development of Mycobacterium tuberculosis amino acid biosynthesis pathway inhibitor DRILS-1398 as a potential anti-TB drug

Year: 2025

Type: article

Abstract: Publisher of over 50 scientific journals across the life, physical, earth, and health sciences, both independently and in partnership with scientific societies including Cell, Neuron, Immunity, Current Biology, AJHG, and the Trends Journals.

Source: iScience

DOI: 10.1016/j.isci.2025.112537

Authors: Deepesh Biswas, Rebecca Kristina Edwin, K. Shiva Kumar, Anwar Alam, Dhiraj Kumar, Sandipan Chakraborty, Gopalakrishnan Bulusu, Farhan Jalees Ahmad, Gautham G. Shenoy, Lakshyaveer Singh, Mansi Agarwal, Fouzia Siraj, Srinivas Oruganti, Parimal Misra, Nasreen Zafar Ehtesham, Manojit Pal, Seyed Ehtesham Hasnain

Institutions: Manipal Academy of Higher Education, University of Hyderabad, Sharda University, International Centre for Genetic Engineering and Biotechnology, Jamia Hamdard, Safdarjang Hospital, Indian Council of Medical Research, Indian Institute of Technology Delhi

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,240

Funders: Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India, Science and Engineering Research Board

Awards: G1573314316, G3027038225, G4194653994, G5272385675, G7480052864, G8354475299

OpenAlex ID: W4409912097

FWCI: 2.822

Cites: 59

Cited by: 4

Related to: 10